首页> 外文OA文献 >Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial

【2h】

Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial

机译：Neoadjuvant ChemorAdiotherapy，然后是手术与手术单独用于局部晚期鳞状细胞癌的食道（Neocrtec5010）：III期多中心，随机，开放标签临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Hong Yang; Hui Liu; Yuping Chen; Chengchu Zhu; Wentao Fang; Zhentao Yu; Weimin Mao; Jiaqing Xiang; Yongtao Han; Zhijian Chen; Haihua Yang; Jiaming Wang; Qingsong Pang; Xiao Zheng; Huanjun Yang; Tao Li; Florian Lordick; Xavier Benoit D’Journo; Robert J. Cerfolio; Robert J. Korst; Nuria M. Novoa; Scott J. Swanson; Alessandro Brunelli; Mahmoud Ismail; Hiran C. Fernando; Xu Zhang; Qun Li; Geng Wang; Baofu Chen; Teng Mao; Min Kong; Xufeng Guo; Ting Lin; Mengzhong Liu; Jianhua Fu;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial [J] . Yang Hong, Liu Hui, Chen Yuping, Journal of Clinical Oncology . 2018 ,第27期

机译：Neoadjuvant ChemorAdiotherapy，然后是手术与手术单独用于局部晚期鳞状细胞癌的食道（Neocrtec5010）：III期多中心，随机，开放标签临床试验
2. Cost-effectiveness analysis of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced esophageal squamous cell carcinoma based on the NEOCRTEC5010 trial [J] . Zhan Mei, Zheng Hanrui, Yang Yu, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2019 ,第期

机译：Neoadjuvant Chemoradootherapy的成本效果分析，随后单独进行手术与局部晚期食管鳞状细胞癌的手术，基于NeocroC5010试验
3. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT 3-4a N 0-1 M 0 ) (NCT03001596) [J] . Han Tang, Lijie Tan, Yaxing Shen, BMC Cancer . 2017 ,第1期

机译：CMISG1701：一项多中心前瞻性随机III期临床试验，比较了局部晚期可切除食管鳞状细胞癌（cT 3-4a N 0-1 M 0）的患者中新辅助放化疗与新辅助化疗后再进行微创食管切除术（NCT03001596）
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. Randomized clinical trials evaluating therapeutic influences of ornamental indoor plants in hospital rooms on health outcomes of patients recovering from surgery [D] . Park, Seong-Hyun 2006

机译：评估医院室内观赏室内植物对手术康复患者健康结局的治疗影响的随机临床试验
6. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter Randomized Open-Label Clinical Trial [O] . Hong Yang, Hui Liu, Yuping Chen, -1

机译：新辅助放化疗后再行手术与单独手术治疗食管局部晚期鳞状细胞癌（NEOCRTEC5010）：III期多中心随机开放标签临床试验
7. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903) [O] . Hai-Bo Sun, Wen-Qun Xing, Xian-Ben Liu, 2020

机译：Neoadjuvant化疗与Neoadjuvant Chemoradiotherapatia治疗局部晚期食管鳞状细胞癌：单中心，开放标签，随机，控制，临床试验（HCHTOG1903）

Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial

著录项

相似文献

相关主题

期刊订阅